About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety and Efficacy of Combigan® Ophthalmic Solution in Korea

NCT01987752·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Allergan

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with Open Angle Glaucoma or Ocular Hypertension treated with Combigan® Ophthalmic Solution as standard of care in clinical practice.

You may not be if

None.

The record

StatusCompleted

PhaseNo phase

Taking part732

StartedJan 2009

UpdatedApr 4, 2014

Conditions

Glaucoma, Open-Angle Ocular Hypertension

Where1

Seoul, South Korea

Clareo Health | Safety and Efficacy of Combigan® Ophthalmic Solution in Korea